Efflux Pump Mediated Azole Resistance in Candida Albicans Among Neutropenic Patients With Haematological Malignancies

Unknown NCT03659162

Study Description

Candida albicans is the major fungal pathogen causing infections in humans, ranging from superficial mucosal infection to systemic mycoses. In recent years, Candida infections have increased disproportionately as a result of the increased number of compromised host populations, such as patients with AIDS, diabetes and various cancers, and organ-transplant recipients. Severe oro-pharyngeal candidiasis afflicts many AIDS patients and is a significant infection in cancer patients being treated with chemotherapy and/or radiotherapy.

Study Details

Registry ID:
NCT03659162
Conditions:
Fungal Infection
Phase:
Target Enrollment:
100 participants
Start Date:
Age Range:
0–999 years
Healthy Volunteers:
No

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →